You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
|
|---|---|
| Published in |
European Respiratory Journal, May 2008
|
| DOI | 10.1183/09031936.00002108 |
| Pubmed ID | |
| Authors |
P. L. P. Brand, E. Baraldi, H. Bisgaard, A. L. Boner, J. A. Castro-Rodriguez, A. Custovic, J. de Blic, J. C. de Jongste, E. Eber, M. L. Everard, U. Frey, M. Gappa, L. Garcia-Marcos, J. Grigg, W. Lenney, P. Le Souëf, S. McKenzie, P. J. F. M. Merkus, F. Midulla, J. Y. Paton, G. Piacentini, P. Pohunek, G. A. Rossi, P. Seddon, M. Silverman, P. D. Sly, S. Stick, A. Valiulis, W. M. C. van Aalderen, J. H. Wildhaber, G. Wennergren, N. Wilson, Z. Zivkovic, A. Bush |
| Abstract |
There is poor agreement on definitions of different phenotypes of preschool wheezing disorders. The present Task Force proposes to use the terms episodic (viral) wheeze to describe children who wheeze intermittently and are well between episodes, and multiple-trigger wheeze for children who wheeze both during and outside discrete episodes. Investigations are only needed when in doubt about the diagnosis. Based on the limited evidence available, inhaled short-acting beta(2)-agonists by metered-dose inhaler/spacer combination are recommended for symptomatic relief. Educating parents regarding causative factors and treatment is useful. Exposure to tobacco smoke should be avoided; allergen avoidance may be considered when sensitisation has been established. Maintenance treatment with inhaled corticosteroids is recommended for multiple-trigger wheeze; benefits are often small. Montelukast is recommended for the treatment of episodic (viral) wheeze and can be started when symptoms of a viral cold develop. Given the large overlap in phenotypes, and the fact that patients can move from one phenotype to another, inhaled corticosteroids and montelukast may be considered on a trial basis in almost any preschool child with recurrent wheeze, but should be discontinued if there is no clear clinical benefit. Large well-designed randomised controlled trials with clear descriptions of patients are needed to improve the present recommendations on the treatment of these common syndromes. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| Italy | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 513 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | <1% |
| United States | 3 | <1% |
| Australia | 2 | <1% |
| Portugal | 2 | <1% |
| Canada | 2 | <1% |
| United Kingdom | 2 | <1% |
| Korea, Republic of | 1 | <1% |
| France | 1 | <1% |
| India | 1 | <1% |
| Other | 5 | <1% |
| Unknown | 491 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 74 | 14% |
| Other | 57 | 11% |
| Student > Master | 55 | 11% |
| Student > Ph. D. Student | 51 | 10% |
| Researcher | 47 | 9% |
| Other | 117 | 23% |
| Unknown | 112 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 289 | 56% |
| Agricultural and Biological Sciences | 17 | 3% |
| Nursing and Health Professions | 16 | 3% |
| Biochemistry, Genetics and Molecular Biology | 10 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 1% |
| Other | 38 | 7% |
| Unknown | 136 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2019.
All research outputs
#1,494,828
of 25,998,826 outputs
Outputs from European Respiratory Journal
#931
of 8,977 outputs
Outputs of similar age
#3,532
of 100,672 outputs
Outputs of similar age from European Respiratory Journal
#3
of 43 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,977 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.2. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 100,672 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.